CORT · NASDAQ · Medical - Pharmaceuticals

Corcept Therapeutics (CORT)

Develops cortisol-modulating medicines for endocrine disease and cancer.

$117.51
After hours+0.05 (+0.04%)
At close$117.46(+3.25%)
  1. Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report?

    Zacks Investment ResearchMarket move